Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

CUSIP: 03209R103

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
46,377,939
Total 13F shares
35,163,514
Share change
-127,660
Total reported value
$1,305,816,189
Put/Call ratio
30%
Price per share
$37.13
Number of holders
261
Value change
-$16,188,647
Number of buys
111
Number of sells
147

Quarterly Holders Quick Answers

What is CUSIP 03209R103?
CUSIP 03209R103 identifies AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Jack Y. Zhang
13D/G
25%
12,524,153
$301,456,363 $0 31 Dec 2024
BlackRock, Inc.
13F
Company
13%
6,032,722
$292,768,000 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
5.8%
2,711,473
$131,587,785 30 Sep 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
4.6%
2,135,038
$102,524,525 30 Sep 2024
13F
FEDERATED HERMES, INC.
13F
Company
4.2%
1,947,100
$94,492,763 30 Sep 2024
13F
Neuberger Berman Group LLC
13F
Company
3.5%
1,615,088
$78,380,221 30 Sep 2024
13F
STATE STREET CORP
13F
Company
3.3%
1,530,464
$74,273,418 30 Sep 2024
13F
Mary Z. Luo
3/4/5
COO,Chief Scientist & Chairman, Director, 10%+ Owner
class O/S missing
1,109,416
$63,239,930 10 Jan 2024
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
2.7%
1,260,767
$61,185,045 30 Sep 2024
13F
Epoch Investment Partners, Inc.
13F
Company
2.6%
1,191,110
$57,804,568 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2.4%
1,093,302
$53,057,036 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2%
920,363
$44,673,682 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
1.5%
677,626
$32,885,189 30 Sep 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
1.4%
639,592
$31,039,400 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
1.3%
583,362
$28,310,558 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.2%
568,894
$27,609,000 30 Sep 2024
13F
MARSHALL WACE, LLP
13F
Company
1.2%
568,494
$27,589,013 30 Sep 2024
13F
Boston Trust Walden Corp
13F
Company
1.2%
539,639
$26,188,681 30 Sep 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.1%
489,400
$23,750,582 30 Sep 2024
13F
BESSEMER GROUP INC
13F
Company
1%
477,021
$23,150,000 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.97%
449,389
$21,808,848 30 Sep 2024
13F
Mesirow Institutional Investment Management, Inc.
13F
Company
0.89%
413,949
$20,088,945 30 Sep 2024
13F
Granite Investment Partners, LLC
13F
Company
0.87%
405,718
$19,689,495 30 Sep 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.75%
350,056
$16,988,218 30 Sep 2024
13F
Invesco Ltd.
13F
Company
0.72%
332,925
$16,156,851 30 Sep 2024
13F
Portolan Capital Management, LLC
13F
Company
0.71%
327,764
$15,906,387 30 Sep 2024
13F
BOONE CAPITAL MANAGEMENT LLC
13F
Company
0.68%
316,556
$15,362,463 30 Sep 2024
13F
Richard Koo
3/4/5
Director
mixed-class rows
286,471
mixed-class rows
$15,350,254 07 Jun 2021
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.58%
266,863
$12,996,228 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.56%
259,650
$12,600,814 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.55%
253,751
$12,314,537 30 Sep 2024
13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
13F
Company
0.48%
222,620
$10,803,749 30 Sep 2024
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.47%
218,531
$10,605,309 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.45%
207,972
$10,092,881 30 Sep 2024
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.44%
202,017
$9,803,884 30 Sep 2024
13F
SILVERCREST ASSET MANAGEMENT GROUP LLC
13F
Company
0.36%
168,472
$8,175,946 30 Sep 2024
13F
Assenagon Asset Management S.A.
13F
Company
0.36%
167,355
$8,121,738 30 Sep 2024
13F
OBERWEIS ASSET MANAGEMENT INC/
13F
Company
0.35%
161,155
$7,820,852 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.34%
158,131
$7,674,096 30 Sep 2024
13F
Clark Capital Management Group, Inc.
13F
Company
0.33%
153,747
$7,461,342 30 Sep 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.32%
147,045
$7,135,757 30 Sep 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.31%
144,598
$7,017,342 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.29%
135,237
$6,563,052 30 Sep 2024
13F
LAM GROUP, INC.
13F
Company
0.28%
130,800
$6,347,724 30 Sep 2024
13F
FRONTIER CAPITAL MANAGEMENT CO LLC
13F
Company
0.27%
123,619
$5,999,242 30 Sep 2024
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.27%
123,445
$5,990,786 30 Sep 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.25%
116,678
$5,662,383 30 Sep 2024
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.25%
116,677
$5,662,335 30 Sep 2024
13F
Legal & General Group Plc
13F
Company
0.22%
104,323
$5,062,793 30 Sep 2024
13F
Weiss Asset Management LP
13F
Company
0.22%
102,358
$4,967,434 30 Sep 2024
13F

Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2024

As of 31 Dec 2024, Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by 261 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,163,514 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, TD ASSET MANAGEMENT INC, STATE STREET CORP, NEUBERGER BERMAN GROUP LLC, Pacer Advisors, Inc., DIMENSIONAL FUND ADVISORS LP, FULLER & THALER ASSET MANAGEMENT, INC., Epoch Investment Partners, Inc., and Boston Trust Walden Corp. This page lists 262 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
276
Q4 2024 holders
261
Holder diff
-15
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .